ATOS study: effectiveness and safety of insulin glargine 300 U/mL in the real world clinical practice in insulin-naïve type 2 diabetic patients in the Russian Federation

ATOS study: effectiveness and safety of insulin glargine 300 U/mL in the real world clinical practice in insulin-naïve type 2 diabetic patients in the Russian Federation

Rationale: Basal insulin glargine 300 U/mL (Gla-300) is a second-generation basal insulin analogue that has comparable efficacy and lower variability compared to the first generation long-acting insulin analogue glargine 100 U/mL. Aim: To assess the effectiveness and safety of Gla-300 in insulin-...

Full description

Bibliographic Details
Main Author: Gagik R. Galstyan
Format: Article
Language:Russian
Published: MONIKI 2022-10-01
Series:Alʹmanah Kliničeskoj Mediciny
Subjects:
glucose control
hypoglycemia
insulin analogue
type 2 diabetes
glargine 300 u/ml
Online Access:https://almclinmed.ru/jour/article/viewFile/1723/1479

Internet

https://almclinmed.ru/jour/article/viewFile/1723/1479

Similar Items